T cell exhaustion is a major barrier to effective tumor immunotherapy [62, 63], with most mechanistic studies focusing on CD8+ T cells, while CD4+ T cell exhaustion is comparatively underexplored. The gene discussed is CD8A; the disease is neoplasm.